Endpoint · otherPOSTapi.magentlab.com /api/calc/nccn_ipi
Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2), Ann Arbor III or IV 1, major-organ extranodal (bone marrow…
Read more
Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2), Ann Arbor III or IV 1, major-organ extranodal (bone marrow, CNS, liver/GI tract, or lung) 1, ECOG ≥2 1; max 8. Low 0–1, low_intermediate 2–3, high_intermediate 4–5, high 6–8. Deterministic published score; not a DLBCL diagnosis or treatment choice; not Shipp IPI, not R-IPI, not CNS-IPI. magent does not assay LDH or stage lymphoma.Overview
Grade?
UNRATED
0 of 30 paid calls toward a letter
Price
$0.005 per call
Paid calls
none yet
delivery unknown until someone pays
More info
Seller?
URL
https://api.magentlab.com/api/calc/nccn_ipi
Seen
first 34 days ago · last 13 hr ago
36 free handshakes
Payment
Pays through
x402
Offered on?
Base USDC
Listed on?
Base
Paid calls
No paid calls yet.
Delivery is unknown until someone pays. A handshake only shows it asks for payment.
Verify it yourself
npx teppi-check https://api.magentlab.com/api/calc/nccn_ipicurl -s https://api.teppi.xyz/v1/trust/cap_01M1A5A4HPB1KZJTYAZ2NYYSKV